Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9189 USD | -6.23% | -10.79% | +79.82% |
19/04 | YS Biopharma Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2023 | CI |
18/04 | YS Biopharma Receives Clinical Trial Approval for Potential Hepatitis B Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+79.82% | 173M | |
-1.56% | 89.22B | |
+2.24% | 40.49B | |
-12.97% | 32.79B | |
+61.72% | 26.23B | |
-20.71% | 14.52B | |
-7.31% | 13.09B | |
-12.64% | 11.5B | |
-42.60% | 11.6B | |
+4.27% | 8.82B |
- Stock Market
- Equities
- YS Stock
- News YS Biopharma Co., Ltd.
- YS Biopharma Says it Obtained US Patent for Immunotherapy Targeting Chronic Hepatitis B; Shares Gain Pre-Bell